← Back to home
Comparison · Analytics

glyrepr vs ibdsim2

A side-by-side editorial comparison of glyrepr and ibdsim2 — release velocity, themes, recent moves, and the top alternatives to consider.

Shared themes:r-packages

glyrepr vs ibdsim2: at a glance

Featureglyrepribdsim2
SectorAnalyticsAnalytics
Velocity score2.52.5
Sparks · 30d00
Top themesglycomics, data-structures, type-system, r-packagesstatistical-genetics, pedigree-analysis, simulation, r-packages
Last editorial update46m ago50m ago
WebsiteVisit →Visit →

What is glyrepr?

The type system the rest of the glycan stack is built on, being hardened one breaking change at a time.

glyrepr defines the vector types for glycan structures and compositions that every sibling package operates on, with names, NA values, resolution levels from basic through intact, and mapping helpers over structure vectors. Structures now convert to and from node and edge tibbles, low-level constructors support name-preserving construction from trusted graphs, and as_glycan_structure() can degrade element-local failures to NA with one aggregated warning instead of failing the whole vector. The monosaccharide table has been normalised so every entry has a generic form, and substituent support keeps widening.

Read the full glyrepr trajectory →

What is ibdsim2?

A pedigree IBD simulator that absorbed its own web app and now optimises for dense marker panels.

ibdsim2 simulates identity-by-descent sharing along chromosomes for arbitrary pedigrees, in both autosomal and X-chromosomal form, with downstream tools for segment statistics, pattern finding and distribution plots. Since 2.1.0 the Shiny front end lives inside the package and launches via launchApp() rather than sitting in a separate repository. The latest release is performance work, with profileSimIBD() substantially sped up for dense marker panels and ibdsim() skipping recombination in pedigree branches that cannot affect the result.

Read the full ibdsim2 trajectory →

glyrepr vs ibdsim2: editorial side-by-side

G
glyrepr
ANALYTICS
2.5

The type system the rest of the glycan stack is built on, being hardened one breaking change at a time.

◆ Current state

glyrepr defines the vector types for glycan structures and compositions that every sibling package operates on, with names, NA values, resolution levels from basic through intact, and mapping helpers over structure vectors. Structures now convert to and from node and edge tibbles, low-level constructors support name-preserving construction from trusted graphs, and as_glycan_structure() can degrade element-local failures to NA with one aggregated warning instead of failing the whole vector. The monosaccharide table has been normalised so every entry has a generic form, and substituent support keeps widening.

◆ Where it's heading

This package sets the pace for the cohort, and its breaking changes show up as compatibility patches in glyanno, glyenzy and glymotif within days. The direction is toward behaving like a well-built vctrs type: 0.10.0 rewrote the internals to support names and NA properly, 0.11.0 made structure level a vector-wide scalar rather than a per-element value, and the recent releases keep making failure explicit rather than silent, with strict input checks and typed errors replacing quiet drops. Dependencies get shed as readily as features get added, with the parallel-mapping arguments and their furrr and future dependencies removed outright in 0.13.0.

◆ Prediction

The graph-table conversions added in 0.13.0 and the name-preserving low-level constructors in 0.14.0 both look like foundations for other packages to build structures programmatically, so expect that surface to firm up next. Given the cadence of breaking changes, a 1.0 that freezes the type semantics is the more consequential thing to watch for.

I
ibdsim2
ANALYTICS
2.5

A pedigree IBD simulator that absorbed its own web app and now optimises for dense marker panels.

◆ Current state

ibdsim2 simulates identity-by-descent sharing along chromosomes for arbitrary pedigrees, in both autosomal and X-chromosomal form, with downstream tools for segment statistics, pattern finding and distribution plots. Since 2.1.0 the Shiny front end lives inside the package and launches via launchApp() rather than sitting in a separate repository. The latest release is performance work, with profileSimIBD() substantially sped up for dense marker panels and ibdsim() skipping recombination in pedigree branches that cannot affect the result.

◆ Where it's heading

Two long-running threads. One is the app as a first-class part of the package, which has been getting input validation, dependency checks and plotting fixes release after release, treating a research GUI as software to be maintained rather than a demo. The other is numerical care: the built-in recombination map was rebuilt in 2.3.0 with better chromosome endpoints and a thinning algorithm that cut it from about 38,000 points to 14,000 without losing accuracy, and IBD segment merging has been made consistent across the realised-coefficient functions. The maintainer flags repeatedly that seeded results may differ across versions, which is the right disclosure for a simulator used in published analyses.

◆ Prediction

The recent work points at further speed on dense panels and continued hardening of app input handling, both of which have appeared in each of the last several releases. Nothing here signals a new modelling capability on the way.

Alternatives to glyrepr and ibdsim2

Other Analytics products tracked by Sparkpulse, ranked by recent ship velocity. Each card links to a full editorial trajectory and lets you pivot into a head-to-head comparison with either glyrepr or ibdsim2.

See all glyrepr alternatives → · See all ibdsim2 alternatives →

Recent activity from glyrepr and ibdsim2

Latest ship moves from both products, interleaved chronologically. ⚡ = editorial spark.

  1. 11d agoibdsim2profileSimIBD() sped up for dense marker panels; segment merging fixed
  2. 26d agoglyreprName-preserving construction from trusted graphs; partial-failure coercion
  3. 1mo agoglyreprStructures convert to and from graph tibbles; parallel mapping dropped
  4. 1mo agoglyreprFaster structure vector creation
  5. 3mo agoglyreprAnomeric position helpers for structures with missing detail
  6. 3mo agoglyreprStructure level becomes a vector-wide scalar; sialic acid shorthand parsed
  7. 6mo agoglyreprReplaces a deprecated dplyr call to silence warnings
  8. 8mo agoibdsim2Segment-distribution merge argument, and function-valued parameters
  9. 1y agoibdsim2Built-in decode19 recombination map rebuilt, cutting 38k points to 14k
  10. 1y agoibdsim2Consistent IBD segment merging across the realised-coefficient functions
  11. 1y agoibdsim2Built-in pedigree labels revised; extra inbred examples added
  12. 1y agoibdsim2The Shiny front end moves into the package and gains X-chromosomal simulation

Frequently asked questions

What is the difference between glyrepr and ibdsim2?

Both compete on the same themes — r-packages — within Analytics. glyrepr and ibdsim2 are shipping at a similar cadence (velocity 2.5 vs 2.5, both within Sparkpulse's "active" band). See the at-a-glance table above for a side-by-side breakdown of velocity, recent sparks, and editorial themes.

Is glyrepr better than ibdsim2?

Sparkpulse doesn't pick a winner — we score release velocity, not feature parity. glyrepr and ibdsim2 are shipping at a similar cadence (velocity 2.5 vs 2.5, both within Sparkpulse's "active" band). For your specific use case, the alternatives sections above list other Analytics products to evaluate alongside.

What are the best alternatives to glyrepr?

Top glyrepr alternatives in Analytics are ranked by recent ship velocity. Browse the "glyrepr alternatives" section above for the current picks, or visit /alternatives/glyrepr for the full list with editorial commentary on each.

What are the best alternatives to ibdsim2?

Top ibdsim2 alternatives in Analytics are ranked by recent ship velocity. Browse the "ibdsim2 alternatives" section above for the current picks, or visit /alternatives/ibdsim2 for the full list with editorial commentary on each.